JMISMDL 18-Nov-2014 In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.
JMISMDL 12-Nov-2014 In the interest of the investors and the capital market, BSEC has expressed its inability to process the application for rights issue of JMI Syringes & Medical Devices Ltd. as it appears that the company has not taken considerable time to decide the rights offer after re-listing of its securities with stock exchange(s), which might help the investors to make informed investment decision.
JMISMDL 02-Nov-2014 Md. Tariq Ullah Pathan, one of the Sponsors of the Company, has further reported that he has completed his sale of 25,000 shares of the Company at prevailing market price through Stock Exchange as announced earlier.
JMISMDL 30-Oct-2014 (Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2014 (July'14 to Sep'14), the Company has reported net profit after tax of Tk. 12.47 million with EPS of Tk. 1.13 as against Tk. 6.73 million and Tk. 0.61 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 36.93 million with EPS of Tk. 3.36 for the period of nine months (Jan'14 to Sep'14) ended on 30.09.2014 as against Tk. 19.98 million and Tk. 1.82 respectively for the same period of the previous year.
JMISMDL 22-Jul-2014 Normal trading of the shares of the Company will resume on 17.07.2014 after record date for EGM only.
JMISMDL 21-Jul-2014 Trading of the shares of the Company will remain suspended on record date i.e., 22.07.2014 for EGM only. Another record date for entitlement of the proposed rights shares to be notified later after obtaining approval from BSEC.
JMISMDL 17-Jul-2014 Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle from 20.07.2014 to 21.07.2014. Trading of the shares of the Company will remain suspended on record date i.e., 22.07.2014 for EGM only. Another record date for entitlement of the proposed rights shares to be notified later after obtaining approval from BSEC.
JMISMDL 13-Jul-2014 In connection with their earlier news disseminated by DSE dated July 02, 2014 the company has further informed as follows: "The board of directors has decided to keep continuation of last board meeting decision that is to reduce the loan liability and meet the working capital requirements Company's paid up capital will be increased by issuing rights share @ 2R:1 i.e. two rights shares for every one existing share held on the record date at an issue price of Tk. 35.00 each (including a premium of Tk. 25.00 per share) subject to the approval of shareholders in the 7th EGM and the Regulatory Authority. Record date for EGM: 22.07.2014. Date, Time & Venue of the 7th EGM will be notified later."
JMISMDL 02-Jul-2014 The Company has informed that the Board of Directors of the Company has approved the following: to reduce the loan liability and meet the working capital requirements the board has decided to increase Company's paid up capital by issuing rights share @ 2R:1 i.e. two rights shares for every one existing share held on the record date at an issue price of Tk. 35.00 each (including a premium of Tk. 25.00 per share) on paid up capital subject to the approval of shareholders in the 15th AGM to be held on July 24, 2014 and the Regulatory Authority. Another record date for entitlement of the proposed rights shares to be notified later after obtaining approval from BSEC.
JMISMDL 22-Jun-2014 Md. Tariq Ullah Pathan, one of the Sponsors of the Company, has expressed his intention to sell 25,000 shares out of his total holding of 1,00,000 shares of the Company at prevailing market price through Stock Exchange within next 30 working days.